SCHEMBL7970326

SCHEMBL7970326

Cc1ncc(CO)c(CO)c1CO

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.70
KDM4E B2RXH2 3/20 0.70
ALDH1A1 P00352 2/20 0.70
HSD17B10 Q99714 1/20 0.70
LMNA P02545 3/20 0.58
PDXK O00764 3/20 0.48
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
AOX1 Q06278 1/20 0.47
TRIM24 O15164 1/20 0.46
TRIM33 Q9UPN9 1/20 0.46
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C19 P33261 1/20 0.40
HIF1A Q16665 1/20 0.40
GAA P10253 1/20 0.39
CA1 P00915 3/20 0.36
CA2 P00918 3/20 0.36
CA9 Q16790 3/20 0.36
HTT P42858 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18912675 0.84 KDM4E (0.68) HPGDKDM4EALDH1A1HSD17B10LMNA
Pyridoxine SCHEMBL30267871 0.83 HPGD (1.00) HPGDKDM4EALDH1A1HSD17B10LMNA
Pyridoxine SCHEMBL2322958 0.83 HPGD (1.00) HPGDKDM4EALDH1A1HSD17B10LMNA
Pyridoxine SCHEMBL3506 0.83 HPGD (1.00) HPGDKDM4EALDH1A1HSD17B10LMNA
Pyridoxine SCHEMBL30877002 0.83 HPGD (1.00) HPGDKDM4EALDH1A1HSD17B10LMNA
Pyridoxine SCHEMBL7588196 0.81 KDM4E (0.96) HPGDKDM4EALDH1A1HSD17B10LMNA
Pyridoxine SCHEMBL8733421 0.81 HPGD (0.96) HPGDKDM4EALDH1A1HSD17B10LMNA
Pyridoxine SCHEMBL42293 0.81 KDM4E (0.96) HPGDKDM4EALDH1A1HSD17B10LMNA
Pyridoxine SCHEMBL3383552 0.81 KDM4E (0.96) HPGDKDM4EALDH1A1HSD17B10LMNA
Pyridoxine SCHEMBL5370659 0.81 HPGD (0.96) HPGDKDM4EALDH1A1HSD17B10LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6274715-B1 SEMISYNTHETIC MACROLIDES, USEFUL IN BACTERIAL INFECTIONS TREATMENT AND PREVENTION, HAS LESS POTENTIAL FOR DEVELOPING RESISTANCE, IMPROVED OR MODIFIED PROFILES OF DESIRED GRAM-NEGATIVE ACTIVITY ABBOTT LABORATORIES 2001-08-14 US disclosed